In a newly published study, a team of Columbia University-based hair loss research scientists report the discovery of a gene causing a rare but distressing form of childhood baldness, a finding that could help the quest to treat common forms of hair loss.  Mutation in a gene called APCDD1 plays a key role in a disease called hereditary hypotrichosis simplex (HHS), which triggers progressive hair loss starting in childhood.

What makes HairGenesis® different from all the rest?  Let's start with the basics.  First, we're in the business of selling a patent pending, USPTO trademark registered, line of hair loss treatment products.  We are the only non-drug hair loss treatment line supported with published peer-reviewed IRB monitored clinical research.  Our latest university-based research study demonstrates a novel mechanism of action and our patent pending application articulates the novelty of our most recently developed dual-mechanism formula. 

The treatment of pattern hair loss has evolved from the use of materials that obviously don't work to those that barely

work to those that have scientific evidence that they actually work very well.  Of late, 21st Century methodology 

allows for the investigation, testing and deployment of new substances as well as known substances used in new ways.

Carnitine is a known substance that is finding new application in the treatment of hair loss.  Here's why.